申请人:Lilly Industries Limited
公开号:US05041461A1
公开(公告)日:1991-08-20
A pharmaceutically-active compound of the formula ##STR1## in which R.sup.1 is C.sub.1-4 alkythio, C.sub.1-4 alkylsulphinyl or C.sub.1-4 alkylsulphonyl, R.sup.2 is C.sub.1-4 alkyl, R.sup.3 is C.sub.1-4 alkyl or C.sub.2-4 alkenyl, and X is (i) --(CH.sub.2).sub.n N(R.sup.4).sub.2 where each R.sup.4 independently is C.sub.1-4 alkyl, C.sub.2-4 alkenyl or optionally substituted C.sub.6 H.sub.5 CH.sub.2 --, and n is 1, 2 or 3, or (ii) a 5- to 8-membered alicyclic group containing one or two nitrogen atoms and directly attached to the amido nitrogen or attached by a C.sub.1-3 alkylene chain; and salts thereof.
一种具有以下结构式的药物活性化合物##STR1## 其中R.sup.1是C.sub.1-4烷硫基,C.sub.1-4烷基磺酰基或C.sub.1-4烷基磺基,R.sup.2是C.sub.1-4烷基,R.sup.3是C.sub.1-4烷基或C.sub.2-4烯基,X是(i)--(CH.sub.2).sub.nN(R.sup.4).sub.2,其中每个R.sup.4独立地是C.sub.1-4烷基,C.sub.2-4烯基或可选地取代的C.sub.6H.sub.5CH.sub.2--,n为1、2或3,或(ii)一种含有一个或两个氮原子的5-至8成员脂环族基,直接连接到酰胺氮或通过C.sub.1-3烷基链连接;以及其盐。